426 related articles for article (PubMed ID: 31502152)
1. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
2. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
3. Exosome: An Emerging Source of Biomarkers for Human Diseases.
Xu L; Wu LF; Deng FY
Curr Mol Med; 2019; 19(6):387-394. PubMed ID: 31288712
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
5. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods.
Greening DW; Xu R; Ji H; Tauro BJ; Simpson RJ
Methods Mol Biol; 2015; 1295():179-209. PubMed ID: 25820723
[TBL] [Abstract][Full Text] [Related]
6. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
[TBL] [Abstract][Full Text] [Related]
8. Exosomal proteins as potential markers of tumor diagnosis.
Li A; Zhang T; Zheng M; Liu Y; Chen Z
J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
Cheng L; Wu S; Zhang K; Qing Y; Xu T
J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
[TBL] [Abstract][Full Text] [Related]
10. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
11. Affibody Functionalized Beads for the Highly Sensitive Detection of Cancer Cell-Derived Exosomes.
Sayyadi N; Zhand S; Razavi Bazaz S; Warkiani ME
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769444
[TBL] [Abstract][Full Text] [Related]
12. Exosomes: an overview of biogenesis, composition and role in ovarian cancer.
Beach A; Zhang HG; Ratajczak MZ; Kakar SS
J Ovarian Res; 2014 Jan; 7():14. PubMed ID: 24460816
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D; Raguraman R; Kim D; Ren X; Munshi A; Moore K; Sikavitsas V; Ramesh R
J Ovarian Res; 2024 May; 17(1):113. PubMed ID: 38796525
[TBL] [Abstract][Full Text] [Related]
14. Challenges in Exosome Isolation and Analysis in Health and Disease.
Ludwig N; Whiteside TL; Reichert TE
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622
[TBL] [Abstract][Full Text] [Related]
15. Exosome beads array for multiplexed phenotyping in cancer.
Jara-Acevedo R; Campos-Silva C; Valés-Gómez M; Yáñez-Mó M; Suárez H; Fuentes M
J Proteomics; 2019 Apr; 198():87-97. PubMed ID: 30594577
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study.
Horie K; Nanashima N; Yokoyama Y; Yoshioka H; Watanabe J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745075
[TBL] [Abstract][Full Text] [Related]
19. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
20. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction.
Li S; Yi M; Dong B; Tan X; Luo S; Wu K
Int J Cancer; 2021 Jun; 148(11):2640-2651. PubMed ID: 33180334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
